Influence of hypoxia and ischemia preconditioning on bilirubin damage to astrocytes

Ana S Falcão1, Rui F M Silva, Adelaide Fernandes

  • 1Centro de Patogénese Molecular-UBMBE, Faculdade de Farmácia, University of Lisbon, Av. Forças Armadas, 1600-083 Lisboa, Portugal.

Brain Research
|March 23, 2007
PubMed

Insights

Perinatal hypoxia-ischemia increases glial cell vulnerability to bilirubin-induced brain damage. This preconditioning enhances cell death and inflammation, raising the risk of encephalopathy in newborns.

Area of Science:

  • Neuroscience
  • Neonatal Medicine
  • Cellular Biology

Background:

  • Perinatal hypoxia-ischemia is a leading cause of childhood neurologic disability and neonatal mortality.
  • Neonatal hyperbilirubinemia, characterized by high unconjugated bilirubin (UCB) levels, can cause brain damage (encephalopathy).
  • Hypoxia-ischemia may increase susceptibility to UCB encephalopathy, but underlying cellular mechanisms are unclear.

Purpose of the Study:

  • To investigate if hypoxia (HP) or oxygen-glucose deprivation (OGD) followed by reoxygenation affects glial cell susceptibility to UCB injury.
  • To elucidate cellular mechanisms linking perinatal insults to increased UCB neurotoxicity.

Main Methods:

  • Cultured astrocytes were subjected to 4 hours of HP or OGD.
  • Cells were reoxygenated for 12 hours before a 4-hour incubation with UCB.
  • UCB toxicity under preconditioned conditions was compared to normoxic controls.

Main Results:

  • HP and OGD preconditioning significantly increased glial cell vulnerability to UCB.
  • Preconditioning enhanced UCB-induced cell death via apoptosis and necrosis.
  • Preconditioning augmented UCB-stimulated inflammatory responses, involving nuclear factor kappaB activation.

Conclusions:

  • Hypoxia and oxygen-glucose deprivation enhance glial cell susceptibility to bilirubin neurotoxicity.
  • These findings reveal a cellular basis for increased brain damage risk in jaundiced newborns with perinatal hypoxic-ischemic events.
  • This study highlights the critical role of glial cell responses in mediating UCB encephalopathy under adverse perinatal conditions.